J. Bellmunt

Pulmonary and Respiratory Medicine · 2009–2020

A researcher in the Science corpus: 20 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom J. Bellmunt trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. A. Billis
  2. Samir S. Taneja
  3. A. Heidenreich
  4. Jonathan I. Epstein

Who trusts J. Bellmunt overall

  1. Rakesh K. Jain
  2. M. Hallek

Papers from J. Bellmunt's perspective

Ordered by how strongly the researchers J. Bellmunt trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (New England Journal of Medicine)
  2. Screening and prostate-cancer mortality in a randomized European study. (New England Journal of Medicine)
  3. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy (New England Journal of Medicine)
  4. AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer (New England Journal of Medicine)
  5. Re: Abiraterone in metastatic prostate cancer without previous chemotherapy. (Journal of Urology)
  6. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. (New England Journal of Medicine)
  7. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study (The Lancet)
  8. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. (Journal of Clinical Oncology)
  9. International variation in prostate cancer incidence and mortality rates. (European Urology)
  10. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. (European Urology)

Their papers